TG02 exhibited potent antiproliferative effects against various tumor cell lines, induced cell-cycle arrest and apoptosis in murine mutant FLT3 leukemia cells, and induced tumor regression and prolonged survival in murine AML models. This evidence concerns the gene FLT3 and acute myeloid leukemia.